(FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | (Q6)Jun 30, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 10.73%3.6B | 0.84%1.93B | -32.73%3.25B | -29.08%1.92B | -5.12%4.83B | 20.30%2.7B | 7.74%5.09B | -6.90%2.25B | -10.09%4.72B | -6.09%2.41B |
Operating income | 10.73%3.6B | 0.84%1.93B | -32.73%3.25B | -29.08%1.92B | -5.12%4.83B | 20.30%2.7B | 7.74%5.09B | -6.90%2.25B | -10.09%4.72B | -6.09%2.41B |
Cost of sales | -7.67%-3.37B | -1.36%-1.77B | 26.70%-3.13B | 26.01%-1.74B | 2.63%-4.27B | -19.39%-2.36B | -13.28%-4.39B | 0.09%-1.97B | 8.90%-3.87B | 5.66%-1.97B |
Operating expenses | -7.67%-3.37B | -1.36%-1.77B | 26.70%-3.13B | 26.01%-1.74B | 2.63%-4.27B | -19.39%-2.36B | -13.28%-4.39B | 0.09%-1.97B | 8.90%-3.87B | 5.66%-1.97B |
Gross profit | 93.96%223.35M | -4.32%167.62M | -79.23%115.16M | -49.76%175.19M | -20.74%554.34M | 26.82%348.73M | -17.57%699.4M | -37.49%274.98M | -15.14%848.49M | -7.98%439.87M |
Selling expenses | -142.48%-189.77M | -9.62%-105.01M | 67.99%-78.26M | 28.90%-95.79M | 10.98%-244.46M | -6.49%-134.74M | -19.50%-274.62M | -7.45%-126.53M | 2.89%-229.82M | -43.65%-117.76M |
Administrative expenses | 3.88%-205.46M | 0.40%-95.29M | 8.19%-213.75M | 6.55%-95.67M | -12.46%-232.8M | -25.15%-102.38M | -2.62%-207M | 25.46%-81.81M | 23.25%-201.71M | 2.91%-109.74M |
Research and development expenses | 26.87%-177.8M | 15.91%-83.63M | 9.93%-243.13M | 2.25%-99.46M | -17.90%-269.93M | -11.76%-101.75M | -7.57%-228.95M | -6.72%-91.04M | -13.25%-212.83M | 1.67%-85.31M |
Impairment and provision | 97.09%-277K | ---- | -1,651.95%-9.53M | ---- | -98.85%614K | ---- | 188.17%53.42M | -382.76%-560K | 25.40%-60.59M | 99.85%-116K |
-Other impairment is provision | 97.09%-277K | ---- | -1,651.95%-9.53M | ---- | -98.85%614K | ---- | 188.17%53.42M | -382.76%-560K | 25.40%-60.59M | 99.85%-116K |
Operating interest expense | ---- | 76.54%-806K | ---- | -425.23%-3.44M | 13.53%-1.37M | 64.65%-654K | -219.08%-1.59M | 10.15%-1.85M | ---498K | ---2.06M |
Special items of operating profit | -23.10%301.3M | -21.24%120.87M | -27.37%391.82M | 18.84%153.46M | 91.53%539.44M | -3.56%129.13M | 10.14%281.64M | 12.63%133.9M | -6.01%255.72M | 13.96%118.88M |
Operating profit | -29.06%-48.65M | -89.05%3.76M | -110.90%-37.69M | -75.21%34.29M | 7.30%345.83M | 29.18%138.34M | -19.18%322.29M | -56.07%107.09M | -20.78%398.77M | 10.50%243.77M |
Financing cost | 64.38%-1.68M | ---- | ---4.72M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Share of profits of associates | 107.77%570K | 85.19%-468K | -30.68%-7.34M | -154.35%-3.16M | -1,397.00%-5.62M | -839.29%-1.24M | 12.76%433K | -47.34%168K | -28.76%384K | 24.12%319K |
Share of profit from joint venture company | -75.28%2.5M | 143.73%1.65M | 135.28%10.13M | -1,708.55%-3.76M | 77.42%4.31M | -71.08%234K | -49.83%2.43M | -36.75%809K | -81.55%4.84M | -92.55%1.28M |
Earning before tax | -19.27%-47.25M | -81.98%4.93M | -111.50%-39.62M | -80.07%27.37M | 5.96%344.52M | 27.08%137.33M | -19.52%325.15M | -55.96%108.06M | -23.80%403.99M | 3.09%245.37M |
Tax | -94.67%1.85M | -1.72%7.09M | 353.97%34.64M | 213.97%7.22M | 27.04%-13.64M | 125.37%2.3M | 60.82%-18.69M | 68.83%-9.06M | 30.50%-47.71M | 28.08%-29.07M |
After-tax profit from continuing operations | -811.24%-45.41M | -65.23%12.02M | -101.51%-4.98M | -75.23%34.58M | 7.97%330.89M | 41.03%139.63M | -13.98%306.46M | -54.23%99.01M | -22.80%356.28M | 9.46%216.3M |
Earning after tax | -811.24%-45.41M | -65.23%12.02M | -101.51%-4.98M | -75.23%34.58M | 7.97%330.89M | 41.03%139.63M | -13.98%306.46M | -54.23%99.01M | -22.80%356.28M | 9.46%216.3M |
Minority profit | -7.61%8.86M | -9.37%5.11M | 8.93%9.59M | 19.63%5.64M | 60.90%8.81M | 6.80%4.71M | -50.13%5.47M | 18.51%4.41M | 41.73%10.97M | 65.98%3.72M |
Profit attributable to shareholders | -272.34%-54.27M | -76.11%6.92M | -104.53%-14.58M | -78.54%28.95M | 7.01%322.08M | 42.63%134.92M | -12.83%300.99M | -55.50%94.59M | -23.90%345.31M | 8.81%212.58M |
Basic earnings per share | -100.00%-0.02 | -76.07%0.0028 | -107.69%-0.01 | -76.60%0.0117 | 8.33%0.13 | 25.00%0.05 | -14.29%0.12 | -55.56%0.04 | -22.22%0.14 | 12.50%0.09 |
Diluted earnings per share | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
Auditor | Deloitte & Touche Certified Public Accountants Limited | -- | Deloitte & Touche Certified Public Accountants Limited | -- | Deloitte & Touche Certified Public Accountants Limited | -- | Deloitte & Touche Certified Public Accountants Limited | -- | Deloitte & Touche Certified Public Accountants Limited | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data